Reuters News Agency
YesterdayReuters
Stocks Medium Importance Neutral
Sandoz results narrowly beat sales expectations

Sandoz results narrowly beat sales expectations

Swiss generic ​maker Sandoz ‌reported a 9% jump ​in second ​quarter net sales ⁠on Wednesday, ​slightly above ​analyst expectations, as it reaped ​the benefits ​of patent expirations ‌in ⁠its biosimilars unit.

Related Symbols 1
SDZNY SDZNY
Source: Reuters
Visit Source
0 0 0
Comment

Comments

0
No comments yet
Be the first person to comment on this news item.